![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 14, 2022 10:54:12 AM
Well I guess I am right and wrong. Doesn’t this kind of support what I wrote? They only want to dump Tollovid/vir. I thought I read they wanted to sell another venture also. Google Fu is not showing any results. As long as it isn’t the testing company. I think the million dollars or so they get from Tollovid/vir a year would not be missed if they can get money to fund the test products launch. There is a few hundred million in revenue there. I just thought Tollovid/vir was kind of their baby. And it produces really good PR and headlines keeping Todos in the news. Why dump it unless you have to? Guess they have to. A lot of investors think Todos and Tollovir/vid. There will be a sell off. Even though it is probably a good strategy. I will probably buy more shares on the dip. I keep telling myself no more! And then I buy 10,000 shares on every dip. Bad 3D. No more shares for you!
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM